Copper Rock Capital Partners LLC boosted its stake in Amedisys Inc (NASDAQ:AMED) by 3.6% during the 4th quarter, Holdings Channel reports. The fund owned 596,014 shares of the health services provider’s stock after acquiring an additional 20,699 shares during the period. Amedisys accounts for 2.0% of Copper Rock Capital Partners LLC’s portfolio, making the stock its 25th biggest position. Copper Rock Capital Partners LLC’s holdings in Amedisys were worth $31,386,000 at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. UBS Asset Management Americas Inc. boosted its holdings in Amedisys by 23.9% in the second quarter. UBS Asset Management Americas Inc. now owns 14,572 shares of the health services provider’s stock valued at $915,000 after acquiring an additional 2,812 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in Amedisys by 29.7% in the third quarter. Wells Fargo & Company MN now owns 1,484,041 shares of the health services provider’s stock valued at $83,048,000 after acquiring an additional 339,825 shares during the last quarter. Castleark Management LLC bought a new stake in Amedisys in the second quarter valued at approximately $3,674,000. Assenagon Asset Management S.A. bought a new stake in Amedisys in the third quarter valued at approximately $1,212,000. Finally, Bank of New York Mellon Corp boosted its holdings in Amedisys by 10.8% in the third quarter. Bank of New York Mellon Corp now owns 846,575 shares of the health services provider’s stock valued at $47,375,000 after acquiring an additional 82,247 shares during the last quarter. Institutional investors and hedge funds own 94.44% of the company’s stock.
Shares of Amedisys Inc (NASDAQ AMED) traded down $2.38 on Monday, reaching $50.51. The company’s stock had a trading volume of 356,192 shares, compared to its average volume of 325,160. Amedisys Inc has a 12-month low of $42.05 and a 12-month high of $65.91. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.33 and a current ratio of 1.33. The firm has a market capitalization of $1,794.91, a price-to-earnings ratio of 40.41, a PEG ratio of 1.13 and a beta of 0.71.
Several brokerages recently commented on AMED. Oppenheimer reiterated a “buy” rating and issued a $60.00 target price on shares of Amedisys in a report on Friday, September 15th. Royal Bank of Canada reiterated a “hold” rating on shares of Amedisys in a report on Monday, October 23rd. Mizuho reiterated a “buy” rating and issued a $65.00 target price (up from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. SunTrust Banks reiterated a “buy” rating and issued a $70.00 target price on shares of Amedisys in a report on Friday, November 10th. Finally, Robert W. Baird upped their target price on Amedisys from $50.00 to $60.00 and gave the company a “neutral” rating in a report on Friday, November 10th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Amedisys presently has a consensus rating of “Buy” and a consensus price target of $61.00.
COPYRIGHT VIOLATION WARNING: “Copper Rock Capital Partners LLC Has $31.39 Million Position in Amedisys Inc (AMED)” was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.com-unik.info/2018/01/08/copper-rock-capital-partners-llc-has-31-39-million-position-in-amedisys-inc-amed.html.
Amedisys Company Profile
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Want to see what other hedge funds are holding AMED? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amedisys Inc (NASDAQ:AMED).
What are top analysts saying about Amedisys? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Amedisys and related companies.